Pierpaolo Sileri Selected Research

Pierpaolo Sileri Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 05/2011
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2011
4	Ulcerative Colitis 01/2022 - 08/2010
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2011
4	Inflammation (Inflammations) 04/2015 - 08/2010
3	COVID-19 06/2022 - 07/2020
3	Neoplasm Metastasis (Metastasis) 11/2018 - 07/2009
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2015 - 08/2010
3	Fistula 10/2014 - 03/2009
2	Crohn Disease (Crohn's Disease) 05/2022 - 08/2010
2	Carcinoma (Carcinomatosis) 02/2022 - 07/2009
2	Adenocarcinoma 02/2022 - 01/2012
2	Abscess 01/2019 - 12/2018
2	Anastomotic Leak 12/2018 - 10/2017
2	Rectal Neoplasms (Rectal Cancer) 12/2018 - 05/2018
2	Rectal Prolapse 10/2017 - 03/2012
2	Colitis 06/2016 - 07/2011
2	Colitis-Associated Neoplasms 04/2015 - 10/2011
2	Rectal Fistula (Anal Fistula) 10/2014 - 03/2011
2	Postoperative Pain 03/2013 - 05/2008
2	Pain (Aches) 03/2013 - 10/2011
1	Virus Diseases (Viral Diseases) 06/2022
1	Colic (Abdominal Cramps) 02/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2021
1	Gangrene 07/2021
1	Lung Neoplasms (Lung Cancer) 07/2021
1	Intestinal Perforation 07/2021
1	Neoplastic Processes 01/2021
1	Stomach Neoplasms (Stomach Cancer) 11/2018
1	Hyperthermia 11/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2015
1	Carcinogenesis 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2015
1	Fissure in Ano (Anal Fissure) 03/2013
1	Spontaneous Remission 03/2013

Drug/Important Bio-Agent (IBA)

3	interleukin-21 (interleukin 21)IBA 04/2015 - 08/2010
3	InterleukinsIBA 04/2015 - 08/2010
3	CytokinesIBA 10/2011 - 08/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2017 - 12/2002
2	6-formylindolo(3,2-b)carbazoleIBA 06/2016 - 07/2011
2	Biological ProductsIBA 03/2015 - 03/2012
2	Dextran SulfateIBA 10/2011 - 07/2011
1	tofacitinibIBA 01/2022
1	Antisense OligonucleotidesIBA 01/2021
1	Fragile X Mental Retardation ProteinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	51 CIBA 07/2020
1	HLA-A Antigens (HLA-A)IBA 07/2020
1	HLA-B Antigens (HLA-B)IBA 07/2020
1	HLA-C Antigens (HLA-C)IBA 07/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2018
1	RamucirumabIBA 11/2018
1	PlatinumIBA 05/2018
1	Hemoglobins (Hemoglobin)IBA 05/2018
1	Capecitabine (Xeloda)FDA Link 05/2018
1	SaltsIBA 05/2018
1	Cisplatin (Platino)FDA LinkGeneric 05/2018
1	human ERBB2 proteinIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2017
1	SuspensionsIBA 10/2017
1	Immunoglobulins (Immunoglobulin)IBA 12/2016
1	Immunoglobulin G (IgG)IBA 12/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2016
1	LigandsIBA 12/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 05/2015
1	Calcibiotic Root Canal SealerIBA 04/2015
1	lissamine rhodamine B (sulforhodamine B)IBA 03/2015
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	AntigensIBA 03/2015
1	EpitopesIBA 03/2015
1	AntibodiesIBA 03/2015
1	Trypan Blue FDA Link 03/2015
1	Myelin P0 Protein (Myelin Protein Zero)IBA 03/2015
1	Caspase 3 (Caspase-3)IBA 03/2015
1	Granzymes (Granzyme)IBA 06/2014
1	Immunoglobulin A (IgA)IBA 06/2014
1	Type A Botulinum Toxins (Botox)FDA Link 03/2013
1	Nitroglycerin (Dynamite)FDA LinkGeneric 03/2013
1	Ointments (Pastes)IBA 03/2013

Therapy/Procedure

4	Therapeutics 05/2008 - 12/2002
3	Drug Therapy (Chemotherapy) 07/2021 - 09/2015
2	Ostomy 06/2022 - 06/2022
2	Colostomy 01/2019 - 12/2018
2	Neoadjuvant Therapy 12/2018 - 05/2018
2	Conservative Treatment 12/2018 - 03/2013
2	Hemorrhoidectomy 10/2011 - 05/2008
1	Operative Surgical Procedures 06/2022
1	Biological Therapy 05/2022
1	Colectomy 02/2022
1	Stents 07/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Ileostomy 10/2017
1	Postoperative Care 01/2017
1	Ligation 10/2014